Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Oct 31, 2025 | (FY)Jul 31, 2025 | (Q4)Jul 31, 2025 | (Q3)Apr 30, 2025 | (Q2)Jan 31, 2025 | (Q1)Oct 31, 2024 | (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 74.44%-254.98K | -7.04%-3.15M | 32.20%-517.05K | 3.12%-920.57K | -31.53%-710.29K | -45.48%-997.55K | -131.79%-2.94M | 1.69%-762.55K | -950.26K | -271.91%-540.04K |
| Net income from continuing operations | 37.48%-813.13K | -36.02%-4.52M | 11.45%-1.04M | -26.06%-983.44K | -103.10%-1.2M | -66.66%-1.3M | -24.32%-3.33M | 24.32%-1.18M | ---780.15K | -20.44%-590.79K |
| Operating gains losses | 106.49%86.22K | 298.92%123.89K | -1.50%36.4K | -33.47%-39.09K | 1,306.78%84.83K | 140.52%41.76K | --31.06K | --36.96K | ---29.29K | --6.03K |
| Depreciation and amortization | -6.18%75.07K | 2.59%317.56K | -45.46%77.2K | 45.08%80.09K | 42.05%80.27K | 42.07%80.01K | 45.40%309.55K | 32.98%141.53K | --55.2K | 6.01%56.5K |
| Other non cashItems | ---- | ---- | ---- | ---- | ---- | ---- | --20K | --0 | --0 | ---- |
| Change In working capital | 118.98%396.87K | 3,347.69%937.5K | 75.16%409.86K | 111.16%21.87K | 1,121.09%324.53K | 762.73%181.23K | -97.72%27.19K | -65.11%233.99K | ---196.02K | -110.88%-31.78K |
| -Change in receivables | 49.52%-10.77K | -85.83%13.54K | -119.59%-3.51K | -22.86%70.17K | -128.57%-31.79K | 82.87%-21.34K | 263.66%95.54K | 113.86%17.9K | --90.97K | 21.05%111.27K |
| -Change in inventory | 120.36%1.42K | -738.85%-28.04K | -34.63%18.99K | -265.95%-8.81K | 12.97%-31.24K | -217.77%-6.98K | -77.54%4.39K | 1,182.95%29.05K | --5.31K | -545.92%-35.89K |
| -Change in prepaid assets | 138.59%5.43K | 2,515.62%9.59K | -104.91%-1.64K | -17.80%3.69K | 146.82%21.61K | -277.69%-14.08K | 97.41%-397 | 276.52%33.35K | --4.49K | -595.79%-46.16K |
| -Change in payables and accrued expense | 79.60%392.7K | 3,976.10%941.78K | 189.21%395.52K | 95.98%-11.95K | 911.01%339.56K | 45.51%218.66K | -97.90%23.11K | -87.89%136.76K | ---297.51K | 129.47%33.59K |
| -Change in other current liabilities | ---- | ---- | ---- | ---- | ---- | 128.16%8.21K | ---- | ---- | ---- | ---- |
| -Change in other working capital | 62.61%8.09K | 100.66%626 | -97.13%486 | -4,412.43%-31.22K | 121.33%26.39K | -53.25%4.97K | -163.30%-95.45K | 130.88%16.93K | --724 | -173.98%-123.73K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 74.44%-254.98K | -7.04%-3.15M | 32.20%-517.05K | 3.12%-920.57K | -31.53%-710.29K | -45.48%-997.55K | -131.79%-2.94M | 1.69%-762.55K | ---950.26K | -271.91%-540.04K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 98.99%-7.47K | 0 | 0 | -78.28%-5.37K | -162.50%-2.1K | -58,505.76%-742.54K | -738.72K | 0 | -3.01K |
| Net PPE purchase and sale | --0 | 98.99%-7.47K | --0 | --0 | ---5.37K | ---2.1K | -58,505.76%-742.54K | ---738.72K | --0 | ---- |
| Net investment purchase and sale | ---- | ---- | ---- | ---- | ---- | -162.50%-2.1K | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | 98.99%-7.47K | --0 | --0 | -78.28%-5.37K | -162.50%-2.1K | -58,505.76%-742.54K | ---738.72K | --0 | ---3.01K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 666.62%240.07K | -81.44%1.07M | -25.53%513.67K | -78.60%643.23K | -108.77%-44.3K | -102.71%-42.37K | 361.71%5.77M | 3.87%689.75K | 3.01M | 97.96%504.94K |
| Net issuance payments of debt | -2,656.15%-1.17M | 85.90%1.02M | -24.78%505.87K | 1,400.80%602.67K | 4.39%-44.3K | -40.32%-42.37K | -43.46%549.68K | 73.56%672.54K | ---46.33K | -118.16%-46.33K |
| Net other financing activities | --1.41M | -99.07%48.37K | -54.65%7.8K | ---- | ---- | ---- | 1,786.06%5.22M | --17.21K | --3.05M | --551.27K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 666.62%240.07K | -81.44%1.07M | -25.53%513.67K | -78.60%643.23K | -108.77%-44.3K | -102.71%-42.37K | 361.71%5.77M | 3.87%689.75K | --3.01M | 97.96%504.94K |
| Net cash flow | ||||||||||
| Beginning cash position | -99.29%14.91K | 15,817.40%2.1M | -99.37%18.28K | -65.38%295.62K | 18.35%1.06M | 15,817.40%2.1M | -60.62%13.18K | 2,230.52%2.91M | 584.00%853.82K | 5,862.54%891.94K |
| Current changes in cash | 98.57%-14.91K | -199.92%-2.08M | 99.58%-3.37K | -113.49%-277.34K | -1,893.85%-759.96K | -218.58%-1.04M | 10,376.67%2.08M | -626.85%-811.53K | --2.06M | -134.69%-38.12K |
| End cash Position | --0 | -99.29%14.91K | -99.29%14.91K | -99.37%18.28K | -65.38%295.62K | 18.35%1.06M | 15,817.40%2.1M | 15,817.40%2.1M | 2,230.52%2.91M | 584.00%853.82K |
| Free cash from | 74.49%-254.98K | 14.35%-3.15M | 65.56%-517.05K | 3.12%-920.57K | -31.59%-715.66K | -45.79%-999.65K | -190.07%-3.68M | -93.23%-1.5M | ---950.26K | -274.54%-543.85K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.